Skip to content
April 24, 2024

Equity.Guru

Investment information for the new generation

Search

January 30, 2021

BioVaxys Technology (BIOV.C) announced today that it that it has initiated the clinical trials for Covid-T, the company’s diagnostic platform for detecting T-cell activity, according to a press release….